Introduction {#s1}
============

Pulmonary embolism (PE) is a common condition that is difficult to diagnose. It has been attempted to obviate the need for the gold standard test, computed tomography pulmonary angiography (CTPA), to diagnose PE. Serving that purpose, D-dimer is a frequently performed test that reliably excludes PE \[[@R01]\]. Unfortunately, it possesses a low specificity in the elderly, pregnant subjects, and cancer patients, reducing the negative predictive power to 30% \[[@R02]\]. Thus, in the ED additional noninvasive bedside tests are needed to reduce costs and morbidity of diagnostic tests for PE.

PE is characterized by lung portions that are adequately ventilated but poorly perfused, which results in a lower amount of CO~2~ released into air and creation of an alveolar dead space \[[@R03]\]. Whereas quantification of dead space and arterial-alveolar CO~2~ tension gradient have been tested in patients with PE, these measurements lack a decent sensitivity to eliminate the possibility of PE in a reliable manner \[[@R04], [@R05]\]. End-tidal carbon dioxide (ETCO~2~), a bedside test, shows vascular occlusion in PE and can reduce side effects of diagnostic tests. It is non-invasive, safe, and cheap. In contrast, dead space can be measured only by collecting exhaled gases and alveolar-arterial gradient necessitates making arterial blood gas analysis \[[@R06]\].

Herein, we aimed to combine clinical probability and end-tidal ETCO~2~ measurement in a prospective manner in order to show whether this approach may exclude or confirm suspected PE.

Materials and Methods {#s2}
=====================

Study design {#s2a}
------------

This study was approved by the scientific research assessment commission and prospectively performed at an emergency department (ED) of an urban training and research hospital, between January 15, 2015 and April 15, 2015. Informed consent form was obtained from the patients and patient relatives.

Patient population and eligibility criteria {#s2b}
-------------------------------------------

A prospectively gathered convenience cohort of 100 subjects, 50 of whom presented to ED with various complaints and were confirmed to have PE with CTPA (study group) based on a high Wells score or a positive plasma D-dimer, and 50 of whom were confirmed to not have PE with CTPA (control group), were eligible for the study. Patients below 18 years, who did not provide a written consent or who refused to participate in the study, who had hypercapnic respiratory failure, neuromuscular disease, pregnancy malignant hyperthermia, bicarbonate infusion, non-invasive ventilation, and oxygen therapy \> 4 L/min that could potentially affect ETCO~2~ level, were excluded from the study.

Patient assessment and data collection {#s2c}
--------------------------------------

Patients who presented to ED and had suspected PE were risk stratified as low, moderate, and high risk according to the Wells scoring system. All patients underwent ETCO~2~ measurement using a capnogrpahy (EMMATM Emergency Capnometer). ETCO~2~ measurements were carried out by placing the capnography device between the endotracheal tube and bag-valve mask (BVM) in intubated patients and by placing it to the tip of the BVM in the non-intubated patients. Patients were instructed to breathe normally and were tested for five breaths in either a supine or seated position. Nostrils were not clipped shut. ETCO~2~ for each breath and respiratory rate was measured.

Age, sex, comorbid conditions, admission symptoms, vital parameters (blood pressure, pulse rate, respiratory rate, body temperature, and oxygen saturation), ETCO~2~, blood gas analyses, D-dimer levels, Wells score \[[@R07]\], and mortality rates were recorded in study forms. Pulmonary CT was used to confirm or exclude pulmonary embolism.

Statistical analysis {#s2d}
--------------------

Statistical analyses were performed with SPSS (Statistical Package for Social Sciences) Windows 19 software package. Normality of distribution of continuous and discrete numerical values was tested using the Kolmogorov-Smirnov test. Descriptive statistics included mean ± standard deviation for continuous numerical variable; median and interquartile range (IQR) for discrete numerical values; and number and percentage (%) for categoric variables. Continuous variables were compared using the Student's *t*-test and Mann-Whitney U-test while the categorical variables were compared using the Chi-square test. Factors affecting pulmonary thromboembolism (PTE) positivity were assessed with logistic regression analysis. The results were presented at a confidence interval of 95% and a statistical significance level of P \< 0.05.

Results {#s3}
=======

The patient group had a mean age of 66.3 ± 18.6 years; the control group had a mean age of 66.0 ± 14.9 years. The two groups were not significantly different with respect to age (P \> 0.05). The patient group consisted of 32 (64%) women and 18 (36%) men; the control group consisted of 22 (44%) women and 28 (56%) men. The PE-positive group had a significantly higher percentage of women (P \< 0.05). The most common comorbid condition in both groups was hypertension. The two groups were not significantly different with respect to the prevalence of comorbid conditions (P \> 0.05).

The PE and non-PE groups had similar primary admission symptoms, state of consciousness, state of intubation, respiratory auscultation findings, blood pressure, pulse rate, respiratory rate, body temperature, and electrocardiograph (ECG) findings (P \> 0.05). A comparison of arterial blood gas analysis revealed no significant inter-group differences for pH, pCO~2~, and HCO~3~ levels but pO~2~ level was significantly lower in the patient group (P \< 0.05). The PE group had a significantly higher hospital admission rate than the non-PE group (P \< 0.05) ([Table 1](#T1){ref-type="table"}).

###### Clinical and Demographical Characteristics of Patients

                       PE, mean ± SD/n (%)   Non-PE, mean ± SD/n (%)   P
  -------------------- --------------------- ------------------------- ----------
  Age                  66.3 ± 18.6           66 ± 14.9                 0.920
  Female               32 (64)               22 (44)                   0.045
  Male                 18 (36)               28 (56)                   
  Comorbidity                                                          
    HT                 29 (58)               23 (460)                  0.230
    DM                 16 (32)               13 (26)                   0.509
    CAD                10 (20)               13 (26)                   0.476
    CHF                10 (20)               8 (16)                    0.603
    DVT                11 (22)               6 (12)                    0.183
    Malignancy         7 (14)                9 (18)                    0.585
    CVA                6 (12)                2 (4)                     0.269
  Admission symptom                                                    
    Dyspnea            25 (50)               28 (56)                   0.224
    Chest pain         22 (44)               18 (36)                   
    Hemoptysis         2 (4)                 0                         
    Palpitation        1 (2)                 4 (8)                     
  Intubation status                                                    
    Yes                0                     2 (4)                     0.153
    No                 50 (100)              48 (96)                   
  Blood pressure                                                       
    Hypertensive       8 (16)                4 (8)                     0.062
    Normotensive       38 (76)               34 (68)                   
    Hypotensive        4 (8)                 12 (24)                   
  Pulse rate                                                           
    \> 120             8 (16)                14 (28)                   0.350
    100 - 120          29 (58)               25 (50)                   
    \< 100             13 (26)               11 (22)                   
  Respiratory rate                                                     
    \> 20              22 (44)               29 (58)                   0.359
    12 - 20            26 (52)               19 (38)                   
    \< 12              2 (4)                 2 (4)                     
  Body temperature                                                     
    Hyperthermia       10 (20)               4 (8)                     0.084
    Normothermia       40 (80)               46 (92)                   
  Blood gas analysis                                                   
    pH                 7.41 ± 0.08           7.42 ± 0.07               0.448
    pO~2~              62.15 ± 10.49         67.85 ± 10.20             0.007
    pCO~2~             33.46 ± 6.22          32.70 ± 6.85              0.559
    HCO~3~             20.65 ± 3.65          21.43 ± 3.88              0.308
  Outcome                                                              
    Admitted           20 (40)               50 (100)                  \< 0.001
    Discharged         30 (60)               0                         

PE: pulmonary embolism; HT: hypertension; DM: diabetes mellitus; CAD: coronary artery disease; CHF: chronic heart failure; DVT: deep vein thrombosis; CVA: cerebrovascular accident.

An analysis of the Wells scores showed that the median Wells score of the PE group was 6 (IQR: 2), and the non-PE group had a median Wells score of 4 (IQR: 1.25). Ten (20%) patients with PE were deemed high risk whereas no subject in the non-PE group was in the high-risk group. The predictive power of the Wells score for PE was significantly greater in the high-risk group (P \< 0.001) ([Fig. 1](#F1){ref-type="fig"}, [Table 2](#T2){ref-type="table"}).

![Comparison of ETCO~2~, D-dimer and Wells scores of the PE and non-PE groups. ETCO~2~: end-tidal carbon dioxide; PE: pulmonary embolism.](jocmr-11-696-g001){#F1}

###### Assessment of the Wells Score

  Wells risk score        CT angiography   P         
  ----------------------- ---------------- --------- ----------
  \< 2 (low risk)         9 (18)           23 (46)   \> 0.001
  2 - 6 (moderate risk)   31 (62)          27 (54)   \> 0.001
  ≥ 7 (high risk)         10 (20)          0         \< 0.001

PE: pulmonary embolism; CT: computed tomography.

The PE group had a median ETCO~2~ of 21 (IQR: 4) and the non-PE group 28.5 (IQR: 6). ETCO~2~ was significantly lower in the PE group (P \< 0.001). The PE group had a median D-dimer of 2,091 ng/mL (IQR: 2,332 ng/mL) while the non-PE group had a median D-dimer level of 2,091 ng/mL (IQR: 2,332 ng/mL). The PE group had a significantly higher D-dimer level than the non-PE group (P \< 0.001) ([Fig. 1](#F1){ref-type="fig"}, [Table 3](#T3){ref-type="table"}).

###### ETCO~2~ and D-Dimer Levels

            PE, median (IQR)   Non-PE, median (IQR)   P
  --------- ------------------ ---------------------- ----------
  ETCO~2~   21 (4)             28.5 (6)               \< 0.001
  D-dimer   2,091 (2,332)      850.5 (1,152)          \< 0.001

ETCO~2~: end-tidal carbon dioxide; PE: pulmonary embolism; IQR: interquartile range.

For diagnosing PE, a cut-off level of 34 mm Hg for ETCO~2~ had a sensitivity of 100%, a specificity of 8%, a positive predictive value (PPV) of 52.1% and a negative predictive value (NPV) of 100%. At a cut-off level of 500 ng/mL, D-dimer had a sensitivity of 100%, a specificity of 18%, a PPV of 54.9% and an NPV of 100%. Wells score, a cut-off level of 4, had a sensitivity of 80%, a specificity of 46%, a PPV of 59.7% and an NPV of 69.7% ([Fig. 2](#F2){ref-type="fig"}, [Table 4](#T4){ref-type="table"}).

![ROC analyses for ETCO~2~, Wells score, and D-dimer level for diagnosing PE. PE: pulmonary embolism; ETCO~2~: end-tidal carbon dioxide; ROC: receiver operating characteristic.](jocmr-11-696-g002){#F2}

###### Comparison of the Sensitivities, Specificities, PPVs, and NPVs of ETCO~2~, Wells Score, and D-Dimer Level for Diagnosing PE

                Area    Cut-off     Sensitivity   Specificity   PPV     NPV
  ------------- ------- ----------- ------------- ------------- ------- -------
  ETCO~2~       0.901   34 mm Hg    100%          8%            52.1%   100%
  D-dimer       0.730   500 ng/mL   100%          18%           54.9%   100%
  Wells score   0.777   4           80%           46%           59.7%   69.7%

PE: pulmonary embolism; ETCO~2~: end-tidal carbon dioxide; PPV: positive predictive value; NPV: negative predictive value.

Factors associated with PE were evaluated with logistic regression analysis. Age and sex were adjusted for the assessment of Wells score and ETCO~2~. The logistic regression analysis was revealed that Wells score and ETCO~2~ were significant predictors of PE ([Table 5](#T5){ref-type="table"}).

###### Logistic Regression Analysis for PE

            B         SE       P       Odds ratio   95% CI for odds ratio   
  --------- --------- -------- ------- ------------ ----------------------- -----------------
  Age       -0.018    0.024    0.458   0.982        0.937                   1.030
  Sex       0.487     0.710    0.493   1.627        0.405                   6.545
  pH        4.323     7.249    0.551   75.433       0.000                   111,697,648.876
  pO~2~     -0.086    0.042    0.037   0.917        0.845                   0.995
  pCO~2~    0.036     0.091    0.692   1.037        0.868                   1.238
  HCO~3~    -0.048    0.133    0.717   0.953        0.735                   1.236
  D-dimer   0.000     0.000    0.092   1.000        1.000                   1.001
  Wells     2.027     0.720    0.005   7.589        1.850                   31.135
  ETCO~2~   -0.519    0.113    0.000   0.595        0.477                   0.743
  Constat   -17.017   54.448   0.755   0.000                                

PE: pulmonary embolism; ETCO~2~: end-tidal carbon dioxide; SE: standard error; CI: confidence interval.

Discussion {#s4}
==========

Among patients admitted to emergency departments, PE is one of the preventable causes of death. In Europe, about 300,000 deaths occur annually due to PE \[[@R08]\]. PE is a highly morbid and mortal disease. Unless timely and adequately treated, it may cause sudden death, and thus swift diagnosis and adequate therapy are mandatory \[[@R9]\]. As it exhibits variable clinical features, diagnosis of PE may be difficult, particularly for emergency physicians. Considering that PE can be confirmed in only 10-15% of patients undergoing diagnostic imaging, and the cost, workload, and possible complications of such studies, novel less invasive tools are needed to be used for diagnosing PE in ED \[[@R10], [@R11]\].

Literature data suggest that the incidence of PE increases proportionately to age, and it occurs more commonly in patients older than 60 years and among women \[[@R12]\]. Previous studies have shown that women suffering PE had higher Wells scores and ECG scores, greater rates of immobilization and surgical interventions, and a higher mean pulmonary artery pressures on echocardiography \[[@R13]\]. Our study also revealed that PE more commonly occurred in women, and the patients had a mean age of 66.3 years.

Comorbidities like respiratory failure, cerebrovascular accident (CVA), acute infectious conditions, acute coronary syndromes (ACSs), chronic heart failure (CHF), and cancer trigger PE and boost mortality \[[@R13]\]. In a study by Riaz et al, the most common comorbid conditions were obesity, hypertension, cancer, chronic lung disease, and cardiovascular diseases \[[@R14]\]. Our study also demonstrated that patients diagnosed with PE had comorbidities, in descending order of hypertension (HT), diabetes mellitus (DM), deep vein thrombosis (DVT), coronary artery disease (CAD), and CHF.

Although the definitive diagnostic method for PE is pulmonary CT angiography (CTA), scoring systems taking into account clinical probabilities serve to determine low-risk patients and avoid unnecessary diagnostic tests, thus preventing adverse clinical outcomes and heavy economic burden when used along with D-dimer as part of a proper diagnostic algorithm \[[@R15]\]. Wells, Geneva, and Gestalt are available scoring systems used for this purpose \[[@R01]\]. Wells scoring uses a three-stage risk scoring. Studies with this clinically validated scoring system have shown that as the score points increased, the probability of PE also increased; although it is incapable of making the diagnosis of PE, when combined with D-dimer level, it is highly important for excluding PE \[[@R16]\]. Our study demonstrated that patients deemed high-risk had a significantly higher Wells score than those without and all of them had a confirmed PE.

Many biochemical markers are used for risk stratifying and excluding PE. Among them, D-dimer, a fibrin degradation product, is decisive in clinical decision making; however, it has a low specificity due to its universal increase in thromboembolic events and unclear cut-off level \[[@R08], [@R17]\]. Nevertheless, its sensitivity approaches to 100% when combined with Wells score \[[@R18]\]. Perrier et al reported that D-dimer was useful for patients admitted to ED with suspected PE \[[@R19]\]. Wells et al reported a diagnostic confirmation rate of 46% when a Wells score of 4 or less was combined with a negative D-dimer test \[[@R20]\]. Our study demonstrated a significantly higher D-dimer level in the PE group than in the non-PE group. The 100% sensitivity allows us to detect virtually every person who has PE but it has relatively low specificity, meaning that it can be falsely positive for a number of patients who actually do not have PE. In this situation, the high NPV (100%) of D-dimer level can safely exclude the possibility of PE in patients with a low probability of PE. However, again a negative value is not safe for excluding PE in patients with a high clinical probability; hence, D-dimer cannot be used for making the diagnosis of PE, and the gold standard is CTPA \[[@R21]\].

Patients with PE show arterial blood gas changes depending on emboli size, obstruction severity, and underlying condition \[[@R22]\]. Hypoxemia and alveolar-arterial oxygen gradient, a more sensitive parameter than hypoxia/hypocapnia, are the most commonly observed arterial blood gas changes; AaDO~2~ is a more valuable parameter for diagnosing PE \[[@R23]\]. Arterial blood gas analysis of our patients revealed a significantly lower PO~2~ level in PE positive ones, as reported in the previous literature \[[@R02]\].

ETCO~2~, measured in exhaled breath and indicating mean alveolar CO~2~ level produced by varying levels of ventilation and perfusion in the lungs, is mostly used to verify the correct location of intubation tube in the ED \[[@R14]\]. However, as ETCO~2~ reflects dead space that defines well ventilated but poorly perfused alveoli and measurements with pulmonary capnography provide valuable information about pulmonary blood flow during alveolar ventilation, this parameter has been shown to be feasible in both diagnosis and determining treatment success in conditions affecting pulmonary blood flow like PE \[[@R05], [@R24]\]. Studies aimed to explore novel rapid and non-invasive methods have revealed that the PE diagnosis was confirmed in a high percentage of patients with a high PE clinical probability and a low ETCO~2~ level \[[@R02]\]. Sanchez et al reported that capnographically measured dead space had a sensitivity of 68.5% and a specificity of 81.5% \[[@R25]\]. Our study revealed a significantly lower ETCO~2~ level in the PE group. Furthermore, it was 28.5 mm Hg on average in the group with excluded PE. For an ETCO~2~ cut-off value of 34, the sensitivity was 100%, specificity 8%, PPV 52.1%, and NPV 100%. Hemnes et al reported a sensitivity of 87%, specificity of 53%, and NPV of 97% for a cut-off level of 36 mm Hg \[[@R06]\]. As we mentioned above, the high sensitivity, low specificity can be falsely positive for a number of patients who actually do not have PE. In this situation, the high NPV (100%) of ETCO~2~ level can safely exclude the possibility of PE in patients with a low probability of PE. However, capnographic measurements alone are insufficient to exclude the diagnosis of PE but serve to make a diagnosis eliminating advanced workup when combined with clinical probability \[[@R25]\].

Conclusions {#s4a}
-----------

We reached a conclusion that ETCO~2~ measurement, as a noninvasive technique, may be used as a diagnostic method for diagnosing PTE among patients who present to ED with suspected PE. However, we are of the opinion that larger studies are needed in this subject, and that ETCO~2~ measurement would have an important role in ED if those studies would support our findings.
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